Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BLRX |
---|---|---|
09:32 ET | 8502 | 0.622 |
09:36 ET | 2350 | 0.622 |
09:38 ET | 4998 | 0.6399 |
09:39 ET | 415 | 0.622 |
09:41 ET | 200 | 0.636498 |
09:59 ET | 703 | 0.621 |
10:01 ET | 11191 | 0.6152 |
10:12 ET | 5115 | 0.630001 |
10:17 ET | 3201 | 0.62 |
10:32 ET | 150 | 0.62 |
10:37 ET | 1000 | 0.62 |
10:42 ET | 1000 | 0.625 |
10:46 ET | 700 | 0.6399 |
10:50 ET | 1000 | 0.63 |
10:51 ET | 2700 | 0.62 |
10:57 ET | 147 | 0.6399 |
11:00 ET | 250 | 0.6299 |
11:06 ET | 2500 | 0.6399 |
11:09 ET | 441 | 0.62 |
11:15 ET | 1200 | 0.62 |
11:22 ET | 140 | 0.629951 |
11:38 ET | 600 | 0.62 |
11:54 ET | 300 | 0.6296 |
12:00 ET | 433 | 0.624851 |
12:09 ET | 100 | 0.6296 |
12:20 ET | 400 | 0.6248 |
12:21 ET | 100 | 0.6295 |
12:23 ET | 100 | 0.62 |
12:32 ET | 3436 | 0.6206 |
12:48 ET | 233 | 0.6206 |
12:52 ET | 318 | 0.622745 |
01:01 ET | 1898 | 0.621 |
01:03 ET | 316 | 0.6215 |
01:12 ET | 100 | 0.6215 |
01:15 ET | 5436 | 0.62 |
01:32 ET | 200 | 0.6236 |
01:46 ET | 200 | 0.6236 |
01:50 ET | 850 | 0.620201 |
02:04 ET | 300 | 0.6299 |
02:20 ET | 2113 | 0.6264 |
02:24 ET | 100 | 0.623 |
02:26 ET | 5600 | 0.623 |
02:31 ET | 438 | 0.6297 |
02:47 ET | 10677 | 0.6199 |
02:49 ET | 2600 | 0.619 |
02:51 ET | 400 | 0.624299 |
02:54 ET | 200 | 0.6295 |
02:56 ET | 395 | 0.624299 |
02:58 ET | 400 | 0.6243 |
03:00 ET | 200 | 0.6243 |
03:02 ET | 289 | 0.6296 |
03:07 ET | 600 | 0.6296 |
03:09 ET | 640 | 0.6243 |
03:12 ET | 200 | 0.6243 |
03:14 ET | 400 | 0.6243 |
03:16 ET | 200 | 0.6296 |
03:27 ET | 157 | 0.6191 |
03:30 ET | 1000 | 0.619 |
03:36 ET | 200 | 0.6191 |
03:43 ET | 1600 | 0.62 |
03:45 ET | 1500 | 0.619 |
03:48 ET | 149 | 0.6193 |
03:54 ET | 3529 | 0.615 |
03:56 ET | 927 | 0.6155 |
03:59 ET | 6373 | 0.6222 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
BioLine RX Ltd | 51.5M | -0.7x | --- |
Dyadic International Inc | 47.2M | -5.9x | --- |
Kezar Life Sciences Inc | 56.0M | -0.5x | --- |
Palatin Technologies Inc | 32.9M | -0.9x | --- |
Kronos Bio Inc | 62.5M | -0.5x | --- |
Evogene Ltd | 34.9M | -1.3x | --- |
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $51.5M |
---|---|
Revenue (TTM) | $4.8M |
Shares Outstanding | 79.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.49 |
EPS | $-0.95 |
Book Value | $0.18 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | 10.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,035.29% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.